TSMC August 2011 Sales Report
Hsinchu, Taiwan, R.O.C. –September 9, 2011 - TSMC (TWSE: 2330, NYSE: TSM) today announced its net sales for August 2011: On an unconsolidated basis, net sales were approximately NT$37.04 billion, an increase of 6.1 percent over July 2011 and an increase of 1.5 percent over August 2010. Revenues for January through August 2011 totaled NT$282.35 billion, an increase of 7.2 percent compared to the same period in 2010.
On a consolidated basis, net sales for August 2011 were approximately NT$ 37.64 billion, an increase of 6.2 percent over July 2011 and an increase of 0.7 percent over August 2010. Consolidated revenues for January through August 2011 totaled NT$288.96 billion, an increase of 6.3 percent compared to the same period in 2010.
"In August, we have completed some rush orders for customers, therefore, TSMC's third quarter revenue is likely to exceed the guidance given on July 28, 2011 (consolidated revenues between NT$102 billion and NT$104 billion)," said Senior Vice President Ms. Lora Ho, TSMC's Chief Financial Officer and Spokesperson. "However, given the increased uncertainty in the global economy, TSMC does not expect that these short-term rush orders will continue into the fourth quarter."
|
Related News
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |